NuvoAir: Funding, Investors & Team (Aug 2026)
NuvoAir is a leading digital health company for chronic disease management and decentralized clinical trials. The NuvoAir Home platform blends connected devices with high-touch care coordination services to enable patients and their providers to proactively manage chronic conditions, resulting in better outcomes and lower costs. NuvoAir Home currently supports thousands of patients worldwide with COPD, cystic fibrosis, severe asthma, IPF, ALS, and muscular dystrophy. NuvoAir's decentralized clinical trial solution has been used in over 30 studies globally across all phases of drug development.
NuvoAir has raised $23.0M across 2 funding rounds on record, the most recent a Series A of $11.0M announced in Jan 2022.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
NuvoAir Company Profile and Key Stats
Latest funding round on record: Jan 2022.
NuvoAir Funding Rounds
NuvoAir raised $12.0M in an undisclosed round announced in Jun 2021.
7 months later, a Series A of $11.0M was announced in Jan 2022.
NuvoAir Founders and Leadership Team
Contact details for the NuvoAir team: 1 of 1 has an email address on file.
Start 14-day free trial →NuvoAir Funding Compared to Other Health Care Startups
NuvoAir's latest round of $11.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NuvoAir in Health Care and Boston
Companies Similar to NuvoAir
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…
NuvoAir Funding FAQs
What does NuvoAir do?
NuvoAir is a leading digital health company for chronic disease management and decentralized clinical trials. The NuvoAir Home platform blends connected devices with high-touch care coordination services to enable patients and their providers to proactively manage chronic conditions, resulting in better outcomes and lower costs. NuvoAir Home currently supports thousands of patients worldwide with COPD, cystic fibrosis, severe asthma, IPF, ALS, and muscular dystrophy. NuvoAir's decentralized clinical trial solution has been used in over 30 studies globally across all phases of drug development.
How much funding has NuvoAir raised?
NuvoAir has raised $23.0M across 2 rounds on record. The most recent is a Series A of $11.0M announced in Jan 2022.
When did NuvoAir last raise funding?
NuvoAir's most recent funding round on record is a Series A of $11.0M, announced in Jan 2022.
Who is the CEO of NuvoAir?
Lorenzo Consoli is listed as CEO at NuvoAir.
Where is NuvoAir headquartered?
NuvoAir is based in Boston, Massachusetts, United States.
How many employees does NuvoAir have?
NuvoAir is in the 51-100 employee band.
How does NuvoAir's funding compare to other Health Care startups?
NuvoAir's latest round of $11.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's NuvoAir Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NuvoAir is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.